Ignite Creation Date:
2024-05-06 @ 8:16 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06316128
Status:
COMPLETED
Last Update Posted:
2024-06-07
First Post:
2024-03-05
Brief Title:
EmploYEd Antithrombotic Therapies in Patients With Acute Coronary Syndromes HOspitalized in iTalian CCUs
Sponsor:
Heart Care Foundation
Organization:
Heart Care Foundation
Study Overview
Official Title:
EmploYEd Antithrombotic Therapies in Patients With Acute Coronary Syndromes HOspitalized in iTalian CCUs
Status:
COMPLETED
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EYESHOT-2
Brief Summary:
This registry has the aim to assess the use of different antithrombotic therapies including untested drug combinations routinely used during the hospitalization phase with their timing route and dose of administration in consecutive patients discharged with a diagnosis NSTEMI or STEMI in Italian Cardiac care Units CCUs during a four-week study period
Detailed Description:
EYESHOT-2 is a prospective multicenter observational nationwide survey of patients discharged with a diagnosis NSTEMI or STEMI admitted to Italian CCUs
The survey will be designed to include all consecutive patients who met the eligibility criteria admitted in hospitals with or without cardiac catheterization laboratories and cardiac surgery facilities during a period of 4 weeks
The survey will be designed to include all consecutive patients who met the eligibility criteria admitted in hospitals with or without cardiac catheterization laboratories and cardiac surgery facilities during a period of 4 weeks
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None